Eli Lilly’s Nexperimental GLP-1 pill helped people lose about 12% of their body weight, with weight loss plateauing for most patients in the 72-week trial,

Some people taking Ozempic, Wegovy, or Mounjaro notice that food suddenly tastes sweeter or saltier, and this subtle shift in flavor perception appears tied to

Although cagrilintide from Novo Nordisk A/S proved less than impressive when paired with GLP-1 agonist semaglutide in a single drug known as Cagrisema, the dual

(MedPage Today) — An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial. At week

A 2024 KFF survey found that about 1 in 8 US adults have used a GLP-1 drug like Ozempic.

If there were a “drug of the summer” award, Ozempic would win hands down. This Glucagon-Like Peptide 1 (GLP-1) receptor agonist, scientifically known as Semaglutide,

For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity,

One in five people who took orforglipron once a day for 72 weeks lost 20% or more of their weight, maker Eli Lilly says A

The arrival of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide marks an important moment in the treatment of obesity and diabetes.

We came across a bullish thesis on Novo Nordisk A/S on Summit Stocks’s Substack by Summit Stocks. In this article, we will summarize the bulls’ thesis

GOGGLEBOX star Amy Tapper today showed off her incredible 7st weight loss and looked slimmer than ever. It comes just weeks after Amy, 25, revealed

Post Content

The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File) 2025-09-16T15:21:19Z

Novo Nordisk NVO has secured European approval to update the label of oral GLP-1 drug for type II diabetes (T2D), Rybelsus (oral semaglutide), to reflect

GEMMA Collins flaunted her three stone weight loss in stunning snaps from her holiday. The glam reality TV star looked slimmer than ever after embarking

We’re headed for a big debate about the appropriateness of using GLP-1 RAs to tackle the childhood obesity epidemic. Medscape

Novo Nordisk reported results from its phase 3 clinical trial for its experimental obesity drug cagrilintide which showed significant weight loss among participants.  The research,

Eli Lilly’s experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several

By MATTHEW PERRONE, AP Health Writer WASHINGTON (AP) — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions

Findings from an international database seem encouraging but could be due to confounders or older GLP-1 receptor agonists. Medscape Medical News

submitted by /u/MassGen-Research [link] [comments]

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious

These were the first trials to examine the effects of a 7.2mg dose of semaglutide on body weight. Caroline Ruda/ Shutterstock A higher dose of

celafon/iStockPhoto Starting around 2023, a curious trend took hold in papers on drug safety monitoring. The number of articles published on an individual drug and

WEIGHT loss injections and weight loss surgery are both effective ways to slim down. But one may lead to longer life and fewer serious health

Nature Medicine, Published online: 16 September 2025; doi:10.1038/s41591-025-03893-3 In an observational study comparing individuals with type 2 diabetes and obesity who underwent metabolic surgery with

Physiologia, Vol. 5, Pages 34: The Cardiovascular Physiology of Glucagon-like Peptide-1 Receptor Agonists: From Macro-Level Outcomes to Micro-Level Mechanisms Physiologia doi: 10.3390/physiologia5030034 Authors: Masab Mansoor

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious

Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to managing patients on GLP-1 therapy. Medscape Medical News

IT’S just 12 weeks until party season, but a summer of barbecues, beers and ice cream may have left its mark on your waistline. Does

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents